(Q34240744)

31 July 2017

1 reference

title

TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept (English)

1 reference

31 July 2017

0 references

1 reference

Mikuls TR

1

1 reference

31 July 2017

Moreland LW

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

75-84

1 reference

Early rheumatoid arthritis: time to aim for remission?

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

The changing face of rheumatoid arthritis therapy: results of serial surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

Cytokines in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.75

21 January 2018

Identifiers

DOI

10.1517/14656566.2.1.75

1 reference

31 July 2017

1 reference